Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Infliximab (Atc Code According To Who: L04Ab02)
Deadline - May 31, 2025
GT reference number - 80162354
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 80162354
Document Type - Tender Notices
Description - Description Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Infliximab (Atc Code According To Who: L04Ab02)local title: Abschluss nicht exkl. Arzneimi ttel-Rabattvereinb. nach ยง 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Infliximab (ATC-Code nach WHO: L04AB02)type_of_procedure: Otherbidding_response_method: Not Available
Gt Ref Id - 80162354
Deadline - May 31, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database